MicroRNAs affecting the susceptibility of melanoma cells to CD8 T cell-mediated cytolysis.
Autorzy:
Pane AA; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany. Kordaß T; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University of Heidelberg, Heidelberg, Germany. Hotz-Wagenblatt A; Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany. Dickes E; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. Kopp-Schneider A; Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany. Will R; Core Facility Cellular Tools, German Cancer Research Center (DKFZ), Heidelberg, Germany. Seliger B; Institute of Medical Immunology, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany. Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. EichmüllerSB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines.
Autorzy:
Hartmann L; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. Schröter P; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital (UKHD), Heidelberg, Germany. Osen W; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Heidelberg, Germany. Baumann D; German Cancer Research Center (DKFZ), Molecular Oncology of Gastrointestinal Tumors, Heidelberg, Germany.; Department of Surgery, Heidelberg University Hospital (UKHD), Heidelberg, Germany. Offringa R; German Cancer Research Center (DKFZ), Molecular Oncology of Gastrointestinal Tumors, Heidelberg, Germany.; Department of Surgery, Heidelberg University Hospital (UKHD), Heidelberg, Germany. Moustafa M; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany.; Faculty of Medicine Heidelberg (MFHD), Division of Molecular and Translational Radiation Oncology, Heidelberg, Germany.; German Cancer Consortium (DKTK) Core-Center Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Clinical Pathology, Suez Canal University, Ismailia, Egypt. Will R; German Cancer Research Center (DKFZ), Genomics and Proteomics Core Facility, Heidelberg, Germany. Debus J; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital (UKHD), Heidelberg, Germany.; Faculty of Medicine Heidelberg (MFHD), Division of Molecular and Translational Radiation Oncology, Heidelberg, Germany.; German Cancer Consortium (DKTK) Core-Center Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany. Brons S; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital (UKHD), Heidelberg, Germany. Rieken S; Department of Radiation Oncology, Heidelberg University Hospital (UKHD), Heidelberg, Germany. .; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany. .; Department of Radiation Oncology, Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg University Hospital (UKHD), Heidelberg, Germany. .; Department of Radiation Oncology, University Medical Center Göttingen, Göttingen, Germany. . EichmüllerSB; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Heidelberg, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Dec 09; Vol. 10 (1), pp. 21517. Date of Electronic Publication: 2020 Dec 09.
Reprogramming of macrophages employing gene regulatory and metabolic network models.
Autorzy:
Hörhold F; Center for Sepsis Control and Care, University Hospital, Jena, Germany. Eisel D; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany. Oswald M; Center for Sepsis Control and Care, University Hospital, Jena, Germany. Kolte A; Center for Sepsis Control and Care, University Hospital, Jena, Germany. Röll D; Center for Sepsis Control and Care, University Hospital, Jena, Germany. Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. EichmüllerSB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. König R; Center for Sepsis Control and Care, University Hospital, Jena, Germany.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2020 Feb 25; Vol. 16 (2), pp. e1007657. Date of Electronic Publication: 2020 Feb 25 (Print Publication: 2020).
Measles Vaccines Designed for Enhanced CD8 T Cell Activation.
Autorzy:
Busch E; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany. Kubon KD; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany. Mayer JKM; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Medical Faculty, Heidelberg University, 69120 Heidelberg, Germany. Pidelaserra-Martí G; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University and Helmholtz International Graduate School for Cancer Research, 69120 Heidelberg, Germany. Albert J; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Hoyler B; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Heidbuechel JPW; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Stephenson KB; McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4K1 Ontario, Canada. Lichty BD; McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON L8S 4K1 Ontario, Canada. Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. EichmüllerSB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Jäger D; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor-Immunity, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Ungerechts G; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Center for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, K1H 8L6 Ontario, Canada. Engeland CE; National Center for Tumor Diseases (NCT), Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.; Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.; Research Group Mechanisms of Oncolytic Immunotherapy, Clinical Cooperation Unit Virotherapy, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Feb 21; Vol. 12 (2). Date of Electronic Publication: 2020 Feb 21.
Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line.
Autorzy:
Schröter P; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; University Hospital Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, D-69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, D-69120, Heidelberg, Germany. Hartmann L; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany. Osen W; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany. Baumann D; German Cancer Research Center (DKFZ), Molecular Oncology of Gastrointestinal Tumors, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; University Hospital Heidelberg, Department of Surgery, Im Neuenheimer Feld 110, D-69120, Heidelberg, Germany. Offringa R; German Cancer Research Center (DKFZ), Molecular Oncology of Gastrointestinal Tumors, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; University Hospital Heidelberg, Department of Surgery, Im Neuenheimer Feld 110, D-69120, Heidelberg, Germany. Eisel D; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany. Debus J; University Hospital Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, D-69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, D-69120, Heidelberg, Germany. EichmüllerSB; German Cancer Research Center (DKFZ), Research Group GMP & T Cell Therapy, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany. . Rieken S; University Hospital Heidelberg, Department of Radiation Oncology, Im Neuenheimer Feld 400, D-69120, Heidelberg, Germany.; Heidelberg Institute of Radiation Oncology (HIRO), Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany.; Heidelberg Ion-Beam Therapy Center (HIT), Im Neuenheimer Feld 450, D-69120, Heidelberg, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jan 20; Vol. 10 (1), pp. 686. Date of Electronic Publication: 2020 Jan 20.
Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.
Autorzy:
Das K; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Eisel D; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Lenkl C; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Goyal A; Division of RNA Biology and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Diederichs S; Division of RNA Biology and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Cancer Research, Dept. of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg & German Cancer Consortium (DKTK), Freiburg, Germany. Dickes E; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Osen W; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. EichmüllerSB; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Mar 16; Vol. 12 (3), pp. e0174077. Date of Electronic Publication: 2017 Mar 16 (Print Publication: 2017).
Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.
Autorzy:
Werner S; Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany. Chen H; Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany. Butt J; Division of Molecular Diagnostics of Oncogenic Infections, DKFZ, Heidelberg, Germany. Michel A; Division of Molecular Diagnostics of Oncogenic Infections, DKFZ, Heidelberg, Germany. Knebel P; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany. Holleczek B; Saarland Cancer Registry, Saarbrücken, Germany. Zörnig I; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany. EichmüllerSB; GMP &T cell Therapy Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany. Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and Heidelberg University Hospital, Heidelberg, Germany. Pawlita M; Division of Molecular Diagnostics of Oncogenic Infections, DKFZ, Heidelberg, Germany. Waterboer T; Division of Molecular Diagnostics of Oncogenic Infections, DKFZ, Heidelberg, Germany. Brenner H; Division of Clinical Epidemiology and Aging Research, DKFZ, Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 May 03; Vol. 6, pp. 25467. Date of Electronic Publication: 2016 May 03.
SOX5 is involved in balanced MITF regulation in human melanoma cells.
Autorzy:
Kordaß T; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. .; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany. . Weber CE; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. . Oswald M; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany. .; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Beutenbergstrasse 11a, 07745, Jena, Germany. . Ast V; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany. .; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Beutenbergstrasse 11a, 07745, Jena, Germany. . Bernhardt M; Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. .; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. . Novak D; Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. .; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. . Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. .; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany. . EichmüllerSB; GMP & T Cell Therapy Unit, German Cancer Research Center (DKFZ), INF 280, 69120, Heidelberg, Germany. . König R; Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany. .; Network Modeling, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena, Beutenbergstrasse 11a, 07745, Jena, Germany. .; Theoretical Bioinformatics, German Cancer Research Center, INF 580, 69121, Heidelberg, Germany. .
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2016 Feb 29; Vol. 9, pp. 10. Date of Electronic Publication: 2016 Feb 29.
miR-137 inhibits proliferation of melanoma cells by targeting PAK2.
Autorzy:
Hao S; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. Luo C; Department of Translational Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Abukiwan A; Department of Translational Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Wang G; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. He J; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. Huang L; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. Weber CE; Department of Translational Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Lv N; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. Xiao X; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China. EichmüllerSB; Department of Translational Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. He D; Key Laboratory of Cell Proliferation and Regulation of Ministry of Education, Universities of the Confederated Institute for Proteomics, Beijing Normal University, Beijing, China.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2015 Dec; Vol. 24 (12), pp. 947-52. Date of Electronic Publication: 2015 Aug 21.
A vaccine targeting mutant IDH1 induces antitumour immunity.
Autorzy:
Schumacher T; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [3]. Bunse L; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [3]. Pusch S; 1] Department of Neuropathology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Sahm F; 1] Department of Neuropathology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Wiestler B; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Quandt J; Department of Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Menn O; Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany. Osswald M; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Oezen I; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Ott M; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Keil M; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Balß J; 1] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Rauschenbach K; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Grabowska AK; Department of Immunotherapy and -prevention Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Vogler I; Ribological GmbH, 55131 Mainz, Germany. Diekmann J; Translational Oncology, 55131 Mainz, Germany. Trautwein N; Department of Immunology, University of Tübingen, 72076 Tübingen, Germany. EichmüllerSB; Department of Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Okun J; Metabolic Centre Heidelberg, University Children's Hospital, 69120 Heidelberg, Germany. Stevanović S; Department of Immunology, University of Tübingen, 72076 Tübingen, Germany. Riemer AB; Department of Immunotherapy and -prevention Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Sahin U; Translational Oncology, 55131 Mainz, Germany. Friese MA; Center for Molecular Neurobiology, University Medical Center, Hamburg-Eppendorf, 20251 Hamburg, Germany. Beckhove P; Department of Translational Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. von Deimling A; 1] Department of Neuropathology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Wick W; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. Platten M; 1] Department of Neurooncology, University Hospital Heidelberg and National Center for Tumor Diseases, 69120 Heidelberg, Germany [2] German Cancer Consortium (DKTK) Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło:
Nature [Nature] 2014 Aug 21; Vol. 512 (7514), pp. 324-7. Date of Electronic Publication: 2014 Jun 25.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
